FIELD: medicine, oncology, pharmacy.
SUBSTANCE: invention relates to an anti-tumor agent representing benzoic acid amide (benzamide). Benzamide is used in the range of doses from 25 to 100 mg/kg.
EFFECT: expanded assortment of agents of indicated designation.
2 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
DRUG WITH ANTIPROLIFERATIVE AND ANTIMETASTATIC EFFECTS AGAINST LEWIS LUNG CARCINOMA WHEN INJECTED INTRAPERITONEALLY | 2022 |
|
RU2792144C1 |
THERAPEUTIC COMBINATIONS CONTAINING INHIBITOR OF POLY(ADP-RIBOSE)POLYMERASE | 2005 |
|
RU2361592C2 |
AGENT FOR POLY(ADP-RIBOSO) POLYMERASE INHIBITION | 2012 |
|
RU2522915C2 |
PLATELET AGGREGATION INHIBITOR SHOWING ANTIMETASTATIC EFFECT | 2001 |
|
RU2192857C1 |
4-{BIS[(HEPTYLTHIO)METHYL]AMINO}BENZAMIDE AND METHOD FOR ITS PRODUCTION | 2022 |
|
RU2796755C1 |
ANTI-TUMOUR AGENT AGAINST LUNG TUMOUR | 2021 |
|
RU2765472C1 |
ANTI-INFLAMMATORY MEDICATION WITH ANTICOAGULANT, ANTITUMOUR AND ANTIMETASTETIC ACTIVITY | 2009 |
|
RU2412712C1 |
TEST-SYSTEM FOR CHEMICAL COMPOUNDS SCREENING FOR INHIBITING ACTIVITY AGAINST PARP-1 | 2016 |
|
RU2649767C1 |
CHEMONUCLEAR METHOD OF PRODUCING TRITIUM-LABELLED QUATERNISED STRUCTURES OF DIAZINE SERIES | 2013 |
|
RU2527115C1 |
COMPOSITION BASED ON AMINO-NITROXYL COMPLEX OF PLATINUM AND DOXORUBICIN AND METHOD OF TREATING TUMORS | 2016 |
|
RU2726826C2 |
Authors
Dates
2005-08-10—Published
2003-12-03—Filed